glp 1 zepbound tirzepatide Zepbound: The newest obesity medication explained by an expert GLP-1 Pricing & Plans |
Description
Org Process Res Dev
2024;20 6 Suppl:S989
It can present as subtle dryness, concentrated urine, constipation, and lightheadedness
Baggio LL, Drucker DJ
The primary ocular concern with GLP-1 receptor agonists has centered on diabetic retinopathy rather than macular degeneration
These effects are often mild to moderate and tend to decrease over time
